MITO25

Trial Description: 
A randomized phase II trial of Carboplatin.-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel.-Bevacizumab-Rucaparib vs Cavboplatin Paclitaxel-Rucaparib in patients with advanced (stage III-B-C-IV ) ovarian, primary peritoneal and fallopian tube cancer preceeded by a phase 1 dose escalation study onn Rucaparib Bevacizumab combination
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Ovarian
Trial Status: 
Recruiting
Contact person: